Function of Survivin in Trophoblastic Cells of the Placenta

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Muschol Steinmetz, Cornelia ^a   Friemel, Alexandra ^a   Kreis, Nina Naomi ^a   Reinhard, Joscha ^b   Yuan, Juping ^a   Louwen, Frank ^a  

^a GOETHE UNIVERSITY   (Germany)

^b St Marien Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN 90; MESSENGER RNA; SERINE; SURVIVIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN BEWO; CELL STRAIN HTR 8 SVNEO; CELL STRAIN JAR; CELL SURVIVAL; CENTROMERE; CENTROSOME; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; METAPHASE; PLACENTA; PREECLAMPSIA; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; STRESS; SURVIVIN GENE; TROPHOBLAST; WESTERN BLOTTING;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS;

EID: 84884386875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073337     Document Type: Article

References (60)

1. Altieri DC, (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70. doi:10.1038/nrc2293. PubMed: 18075512.
2. Mita AC, Mita MM, Nawrocki ST, Giles FJ, (2008) Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005. doi:10.1158/1078-0432.CCR-08-0746. PubMed: 18698017.
3. Vaira V, Lee CW, Goel HL, Bosari S, Languino LR, et al. (2007) Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 26: 2678-2684. doi:10.1038/sj.onc.1210094. PubMed: 17072337.
4. Oh SH, Jin Q, Kim ES, Khuri FR, Lee HY, (2008) Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression. Clin Cancer Res 14: 1581-1589. doi:10.1158/1078-0432.CCR-07-0952. PubMed: 18316583.
5. Guha M, Altieri DC, (2009) Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 8: 2708-2710. doi:10.4161/cc.8.17.9457. PubMed: 19717980.
6. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, et al. (2002) Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115: 575-585. PubMed: 11861764.
7. Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC, (2004) Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 114: 1117-1127. doi:10.1172/JCI22222. PubMed: 15489959.
8. Colnaghi R, Connell CM, Barrett RM, Wheatley SP, (2006) Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281: 33450-33456. doi:10.1074/jbc.C600164200. PubMed: 16950794.
9. Ruchaud S, Carmena M, Earnshaw WC, (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8: 798-812. doi:10.1038/nrm2257. PubMed: 17848966.
10. Sampath SC, Ohi R, Leismann O, Salic A, Pozniakovski A, et al. (2004) The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 118: 187-202. doi:10.1016/j.cell.2004.06.026. PubMed: 15260989.
11. Sandall S, Severin F, McLeod IX, Yates JR III, Oegema K, et al. (2006) A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension. Cell 127: 1179-1191. doi:10.1016/j.cell.2006.09.049. PubMed: 17174893.
12. Wheatley SP, Henzing AJ, Dodson H, Khaled W, Earnshaw WC, (2004) Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J Biol Chem 279: 5655-5660. PubMed: 14610074.
13. Wheatley SP, Barrett RM, Andrews PD, Medema RH, Morley SJ, et al. (2007) Phosphorylation by aurora-B negatively regulates survivin function during mitosis. Cell Cycle 6: 1220-1230. doi:10.4161/cc.6.10.4179. PubMed: 17457057.
14. Colnaghi R, Wheatley SP, (2010) Liaisons between survivin and Plk1 during cell division and cell death. J Biol Chem 285: 22592-22604. doi:10.1074/jbc.M109.065003. PubMed: 20427271.
15. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, et al. (2000) Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 97: 13103-13107. doi:10.1073/pnas.240390697. PubMed: 11069302.
16. Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR, (2001) Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 97: 965-970. doi:10.1016/S0029-7844(01)01131-0. PubMed: 11384704.
17. Ka H, Hunt JS, (2003) Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 163: 413-422. doi:10.1016/S0002-9440(10)63671-1. PubMed: 12875963.
18. Shiozaki A, Kataoka K, Fujimura M, Yuki H, Sakai M, et al. (2003) Survivin inhibits apoptosis in cytotrophoblasts. Placenta 24: 65-76. doi:10.1053/plac.2002.0860. PubMed: 12495661.
19. Fest S, Brachwitz N, Schumacher A, Zenclussen ML, Khan F, et al. (2008) Supporting the hypothesis of pregnancy as a tumor: survivin is upregulated in normal pregnant mice and participates in human trophoblast proliferation. Am J Reprod Immunol 59: 75-83. PubMed: 18154598.
20. Heazell AE, Buttle HR, Baker PN, Crocker IP, (2008) Altered expression of regulators of caspase activity within trophoblast of normal pregnancies and pregnancies complicated by preeclampsia. Reprod Sci 15: 1034-1043. doi:10.1177/1933719108322438. PubMed: 19088373.
21. Li CF, Gou WL, Li XL, Wang SL, Yang T, et al. (2012) Reduced expression of survivin, the inhibitor of apoptosis protein correlates with severity of preeclampsia. Placenta 33: 47-51. doi:10.1016/j.placenta.2011.10.008. PubMed: 22033156.
22. Grill S, Rusterholz C, Zanetti-Dällenbach R, Tercanli S, Holzgreve W, et al. (2009) Potential markers of preeclampsia--a review. Reprod Biol Endocrinol 7: 70. doi:10.1186/1477-7827-7-70. PubMed: 19602262.
23. Redman CW, Sargent IL, (2009) Placental stress and pre-eclampsia: a revised view. Placenta 30 (Suppl A):: S38-S42. doi:10.1016/j.placenta.2008.11.021. PubMed: 19138798.
24. Duley L, (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33: 130-137. doi:10.1053/j.semperi.2009.02.010. PubMed: 19464502.
25. Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J, (2012) A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget 3: 759-773. PubMed: 22929622.
26. Milne F, Redman C, Walker J, Baker P, Bradley J, et al. (2005) The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 330: 576-580. doi:10.1136/bmj.330.7491.576. PubMed: 15760998.
27. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. doi:10.1038/nprot.2008.73. PubMed: 18546601.
28. Meller M, Vadachkoria S, Luthy DA, Williams MA, (2005) Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26: 601-607. doi:10.1016/j.placenta.2004.09.009. PubMed: 16085039.
29. Kreis NN, Sanhaji M, Krämer A, Sommer K, Rödel F, et al. (2010) Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells. Oncogene 29: 5591-5603. doi:10.1038/onc.2010.290. PubMed: 20661218.
30. Sanhaji M, Friel CT, Kreis NN, Krämer A, Martin C, et al. (2010) Functional and spatial regulation of mitotic centromere-associated kinesin by cyclin-dependent kinase 1. Mol Cell Biol 30: 2594-2607. doi:10.1128/MCB.00098-10. PubMed: 20368358.
31. Petroff MG, Phillips TA, Ka H, Pace JL, Hunt JS, (2006) Isolation and culture of term human trophoblast cells. Methods Mol Med 121: 203-217. PubMed: 16251745.
32. Graham CH, (1997) Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta 18: 137-143. doi:10.1016/S0143-4004(97)90085-0. PubMed: 9089774.
33. Yuan J, Sanhaji M, Krämer A, Reindl W, Hofmann M, et al. (2011) Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol 179: 2091-2099. doi:10.1016/j.ajpath.2011.06.031. PubMed: 21839059.
34. Sanhaji M, Kreis NN, Zimmer B, Berg T, Louwen F, et al. (2012) p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Cell Cycle 11.
35. de Sousa AR, Penalva LO, Marcotte EM, Vogel C, (2009) Global signatures of protein and mRNA expression levels. Mol Biosyst 5: 1512-1526. PubMed: 20023718.
36. Gry M, Rimini R, Strömberg S, Asplund A, Pontén F, et al. (2009) Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10: 365. doi:10.1186/1471-2164-10-365. PubMed: 19660143.
37. Vogel C, Marcotte EM, (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227-232. PubMed: 22411467.
38. Kharfi AA, Leblanc S, Ouellet A, Moutquin JM, (2007) Dual action of H2O2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem 40: 94-97. doi:10.1016/j.clinbiochem.2006.10.008. PubMed: 17150203.
39. Dohi T, Xia F, Altieri DC, (2007) Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 27: 17-28. doi:10.1016/j.molcel.2007.06.004. PubMed: 17612487.
40. Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, et al. (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67: 8014-8021. doi:10.1158/0008-5472.CAN-07-1343. PubMed: 17804712.
41. Wang F, Dai J, Daum JR, Niedzialkowska E, Banerjee B, et al. (2010) Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science 330: 231-235. doi:10.1126/science.1189435. PubMed: 20705812.
42. Yamagishi Y, Honda T, Tanno Y, Watanabe Y, (2010) Two histone marks establish the inner centromere and chromosome bi-orientation. Science 330: 239-243. doi:10.1126/science.1194498. PubMed: 20929775.
43. Li F, Altieri DC, (1999) Transcriptional analysis of human survivin gene expression. Biochem J 3442:: 305-311. doi:10.1042/0264-6021:3440305.
44. Van Antwerp DJ, Martin SJ, Verma IM, Green DR, (1998) Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol 8: 107-111. doi:10.1016/S0962-8924(97)01215-4. PubMed: 9695819.
45. Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, Cerni C, (2003) Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22: 4266-4280. doi:10.1038/sj.onc.1206509. PubMed: 12833149.
46. Aoki Y, Feldman GM, Tosato G, (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101: 1535-1542. doi:10.1182/blood-2002-07-2130. PubMed: 12393476.
47. You L, He B, Xu Z, Uematsu K, Mazieres J, et al. (2004) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170-6174. doi:10.1038/sj.onc.1207844. PubMed: 15208662.
48. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M, (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277: 3247-3257. doi:10.1074/jbc.M106643200. PubMed: 11714700.
49. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, et al. (2002) Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21: 2613-2622. doi:10.1038/sj.onc.1205353. PubMed: 11965534.
50. Vaughan JE, Walsh SW, (2012) Activation of NF-kappaB in placentas of women with preeclampsia. Hypertens Pregnancy 31: 243-251. doi:10.3109/10641955.2011.642436. PubMed: 22380486.
51. Ozkan S, Vural B, Filiz S, Coştur P, Dalçik H, (2008) Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic, and neural cell adhesion molecule in preeclampsia. J Matern Fetal Neonatal Med 21: 831-838. doi:10.1080/14767050802251024. PubMed: 18979395.
52. von Versen-Höynck F, Rajakumar A, Parrott MS, Powers RW, (2009) Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms. Placenta 30: 361-367. doi:10.1016/j.placenta.2009.01.004. PubMed: 19203792.
53. Connell CM, Colnaghi R, Wheatley SP, (2008) Nuclear survivin has reduced stability and is not cytoprotective. J Biol Chem 283: 3289-3296. PubMed: 18057009.
54. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR, (2000) The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 11323:: 4363-4371.
55. Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, et al. (2003) Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A 100: 13791-13796. doi:10.1073/pnas.2434345100. PubMed: 14614132.
56. Barrett RM, Osborne TP, Wheatley SP, (2009) Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity. Cell Cycle 8: 278-283. doi:10.4161/cc.8.2.7587. PubMed: 19158485.
57. Harada H, Becknell B, Wilm M, Mann M, Huang LJ, et al. (1999) Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell 3: 413-422. doi:10.1016/S1097-2765(00)80469-4. PubMed: 10230394.
58. Virdee K, Parone PA, Tolkovsky AM, (2000) Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol 10: 1151-1154. doi:10.1016/S0960-9822(00)00702-8. PubMed: 10996800.
59. Knauer SK, Bier C, Habtemichael N, Stauber RH, (2006) The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 7: 1259-1265. doi:10.1038/sj.embor.7400824. PubMed: 17099693.
60. Chan KS, Wong CH, Huang YF, Li HY, (2010) Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis. Cell Death. Drosophila Inf Serv 1: e57.